Ultrasound Evaluation of Carotid Artery Atherosclerotic Plaques and Recanalization

NCT03786666 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1213

Last updated 2023-03-17

No results posted yet for this study

Summary

The purpose of this multiple-center study are: 1) To establish the ultrasound criteria for evaluating vulnerable plaques by comparing the plaque echo characteristics before CEA (carotid artery endarterectomy) and plaque specimen after CEA.

2\) To establish the carotid artery recanalization strategies based on the evaluation results of carotid artery and intracranial artery by color doppler flow imaging and TCCS/TCD (transcranial color coded sonography/transcranial doppler).

3\) To compare the success rate and the incidence of restenosis between CEA and carotid artery stenting.

Conditions

Interventions

PROCEDURE

Carotid artery recanalization CEA or carotid artery stenting

Carotid artery recanalization CEA or carotid artery stenting

Sponsors & Collaborators

  • The First Affiliated Hospital of Soochow University

    collaborator OTHER
  • The First Hospital of Jilin University

    collaborator OTHER
  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER
  • The Second People's Hospital of Liaocheng

    collaborator UNKNOWN
  • Liaocheng Brains Hospital

    collaborator UNKNOWN
  • Lanzhou University Second Hospital

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • Dalian Municipal Central Hospital

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • The Affiliated Hospital of Inner Mongolia Medical University

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Shengli Oilfield Hospital

    collaborator OTHER
  • Zhengzhou First People's Hospital

    collaborator UNKNOWN
  • Weihai Municipal Hospital

    collaborator OTHER
  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Yang Hua, MD · No.45 Changchun Road, Beijing,100053, China

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-16
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786666 on ClinicalTrials.gov